TH77902A - Methods for liver cancer treatment - Google Patents
Methods for liver cancer treatmentInfo
- Publication number
- TH77902A TH77902A TH401000534A TH0401000534A TH77902A TH 77902 A TH77902 A TH 77902A TH 401000534 A TH401000534 A TH 401000534A TH 0401000534 A TH0401000534 A TH 0401000534A TH 77902 A TH77902 A TH 77902A
- Authority
- TH
- Thailand
- Prior art keywords
- liver
- liver cancer
- methods
- mcg
- approximately
- Prior art date
Links
- 208000014018 liver neoplasm Diseases 0.000 title claims abstract 7
- 201000007270 liver cancer Diseases 0.000 title abstract 3
- 210000001367 artery Anatomy 0.000 claims abstract 2
- 206010019695 Hepatic neoplasm Diseases 0.000 claims 4
- 210000004185 liver Anatomy 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 2
- 206010027476 Metastases Diseases 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000009401 metastasis Effects 0.000 claims 1
- CTMCWCONSULRHO-UHQPFXKFSA-N nemorubicin Chemical compound C1CO[C@H](OC)CN1[C@@H]1[C@H](O)[C@H](C)O[C@@H](O[C@@H]2C3=C(O)C=4C(=O)C5=C(OC)C=CC=C5C(=O)C=4C(O)=C3C[C@](O)(C2)C(=O)CO)C1 CTMCWCONSULRHO-UHQPFXKFSA-N 0.000 abstract 2
- 229950010159 nemorubicin Drugs 0.000 abstract 2
- 210000002767 hepatic artery Anatomy 0.000 abstract 1
Abstract
DC60 (09/04/47) การประดิษฐ์นี้เกี่ยวข้องกับตารางการรักษาของเนมอรูบิซิน (nemorubicin) ที่ถูกนำเข้าผ่าน เส้นโลหิตแดงภายในตับในขนาดจากประมาณ 100 mcg/ตารางเมตรถึงประมาณ 800 mcg/ตารางเมตร ทุกๆ 6 อาทิตย์ต่อผู้ป่วยที่เป็นโรคมะเร็งตับ การประดิษฐ์นี้เกี่ยวข้องกับตารางการรักษาของเนมอรูบิซิน (nemorubicin) ที่ถูกนำเข้าผ่าน เส้นโลหิตแดงภายในตับในขนาดจากประมาณ 100 mcg/ตารางเมตรถึงประมาณ 800 mcg/ตารางเมตร ทุก ๆ 6 อาทิตย์ต่อผู้ป่วยที่เป็นโรคมะเร็งตับ DC60 (09/04/47) This invention relates to the treatment schedule of nemorubisin. (nemorubicin) that was imported through Intra-hepatic artery size from approximately 100 mcg / m2 to approximately 800 mcg / m2 every 6 weeks per patient with liver cancer. The invention is related to the treatment schedule of nemorubisin. (nemorubicin) that was imported through Hepatic artery in size from approximately 100 mcg / m2 to approximately 800 mcg / m2 every 6 weeks per patient with liver cancer.
Claims (4)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH77902A true TH77902A (en) | 2006-06-05 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019013701A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents. | |
| MX383644B (en) | COMBINATIONS AND METHODS OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY. | |
| NO2017019I2 (en) | Enzalutamide or a pharmaceutically acceptable salt thereof | |
| EA201301078A1 (en) | NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS | |
| CY1112397T1 (en) | COMBINED TREATMENT FOR CANCER | |
| RU2016102158A (en) | APPLICATION OF ERIBULIN AND LENVATINIB AS A COMBINED THERAPY FOR TREATMENT OF CANCER | |
| ATE543492T1 (en) | TREATMENT OF LUNG CANCER | |
| MX2009003532A (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. | |
| CY1111482T1 (en) | COMBINATION AZD2171 AND PERMETRAXED | |
| MX2007004955A (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally. | |
| EA202191165A1 (en) | ELACESTRANT IN COMBINATION WITH ABEMACYCLIBUS IN WOMEN WITH BREAST CANCER | |
| EA201171360A1 (en) | ANTI-TUMOR COMPLEX, CONTAINING CABAZITAXEL AND CAPETITABINS | |
| EA200801731A1 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF TROBMOCYTHEMIA | |
| EA201000141A1 (en) | NEW TRIAZENES FOR CANCER TREATMENT | |
| NO20075199L (en) | Treatment or prevention of pruritus | |
| DK1971338T3 (en) | Combination of ZD6474 and pemetrexed | |
| JP2009535298A5 (en) | ||
| TH77902A (en) | Methods for liver cancer treatment | |
| RU2015139515A (en) | COMBINED TREATMENT | |
| MX2014001221A (en) | Method for treating cancer by combined use of medicinal agents. | |
| MX2009006670A (en) | Pharmaceutical composition using aliskiren and avosentan. | |
| NO20064754L (en) | combination therapy | |
| RU2007149399A (en) | METHOD FOR TREATING PATIENTS WITH COLORECTAL CANCER WITH LIVER METASTASES | |
| ATE366579T1 (en) | METHOD FOR TREATING LIVER CANCER BY INTRAHEPATIC ADMINISTRATION OF NEMORUBICIN | |
| FR2908131B1 (en) | AMINOBENZOCYCLOHEPTENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THERAPEUTICS |